• Cough in children: treatment options

Cough in children: treatment options

SOVREMENNAYA PEDIATRIYA.2018.4(92):98-104; doi 10.15574/SP.2018.92.98

Kramarov S. O., Zakordonets L. V.
Bogomolets National Medical University, Kyiv, Ukraine

Coughing is one of the most frequent complaints caused seeking medical advice. Treatment of cough in children requires a personalized approach, depend) ing upon the nature of cough, bronchial mucus consistency, sputum volume, the child's age, features of nosological form, etc. The drugs of the Pectolvan line, including Pectolvan Stop, Pectolvan Hedera helix, Pectolvan C, are designed to provide the principle of a personalized approach to cough treatment in adults and children.
Key words: cough, children, treatment, Pectolvan.


1. Ovcharenko LS, Vertehel AO, Samokhin IV (2012). Kashel pry khvorobakh orhaniv dykhannia u ditei. Diahnostyka, likuvannia. Zaporizhzhia: Dyke pole: 116.

2. Savchenko NV, Shumeiko OV. (2009). Zasoby dlia likuvannia kashliu: kliniko-farmakolohichni aspekty. Novosty medytsynы y farmatsyy. 15(289).

3. Selbst SM, Kronen K. (2006). Sekretyi neotlozhnoy pediatrii. Moskva: MEDpress-Inform: 479.

4. Chuchalin AG, Avdeev SN, Arhipov VV. (2004). Ratsionalnaya farmakoterapiya zabolevaniy organov dyihaniya. Rukovodstvo dlya praktikuyuschih vrachey. Moskva: Litera: 104—111.

3. Selbst SM, Kronen K. (2006). Sekretyi neotlozhnoy pediatrii. Moskva: MEDpress-Inform: 479.

4. Chuchalin AG, Avdeev SN, Arhipov VV. (2004). Ratsionalnaya farmakoterapiya zabolevaniy organov dyihaniya. Rukovodstvo dlya praktikuyuschih vrachey. Moskva: Litera: 104—111.

5. Albrecht HH, Dicpinigaitis PV, Guenin EP. (2017, Dec). Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidiscip Respir Med. 11; 12: 31. doi 10.1186/s40248-017-0113-4. eCollection 2017.

6. Chalumeau MY, Duijvestijn CM. (2013). Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst. Rev.5.CD003124. doi 10.1002/14651858.CD003124. pub4. www.cochranelibrary.com

7. Cornford CS, Morgan M, Ridsdale L. (1993). Why domothers consult when their children cough? Fam Pract. 10: 193—6.

8. David R Sibley, Dicpinigaitis PV, Morice AH, Birring SS, McGarvey L, Smith JA, Canning BJ, Antitussive CP. (2014, Apr). Drugs-Past, Present, and Future. Pharmacological Reviews. 66(2): 468—512. doi.org/ 10.1124/pr.111.005116

9. Dicpinigaitis PV, Eccles R, Blaiss MS, Wingertzahn MA. (2015). Impact of cough and common cold on productivity, absenteeism, and daily life in the United States: ACHOO survey. Curr Med Res Opin. 31: 1519—1525.

10. Disse BG, Ziegler HW. (1987). Pharmacodynamic mechanism and therapeutic activity of ambroxol in animal experiments. Respiration. 51; 1: 15—22.

11. Dolansky G, Rieder M. (2008, Feb). What is the evidence for the safety and efficacy of over-the-counter cough and cold preparations for children younger than six years of age? Paediatr Child Health. 13(2): 125—127. PMCID: PMC2528730 PMID: 19183719.

12. FDA Recommends that Over-the-Counter (OTC) Cough and Cold Products not be used for Infants and Children under 2 Years of Age. (2008). http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm051137.html (last accessed 3 October 2009).

13. Food and Drug Administration acts to protect kids from serious risks of opioid ingredients contained in some prescription cough and cold products by revising labeling to limit pediatric use. https://www. fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592109.htm

14. Greunke С, Hage-Hülsmann А, Sorkalla Т et al. (2014). A systematic study on the influence of the main ingredients of an ivy leaves dry extract on the b2-adrenergic responsiveness of human airway smooth muscle cells. http://www.elsevier.com/locate/ypupt, 2014/

15. Hofmann D, Hecker M, Völp A. (2003). Efficacy of dry extract of ivy leaves in children with bronchial asthma — a review of randomized controlled trials. Phytomedicine. 10: 213—220.

16. https://compendium.com.ua/

17. J. Complementary Alternative Medicine, 2011.

18. Kai J. (1996). What worries parents when their preschoolchildren are acutely ill, and why: a qualitative study. BMJ. 313: 983—6.

19. Mark A Malesker, Priscilla Callahan-Lyon, Belinda Ireland, Richard S Irwin on behalf of the CHEST Expert Cough Panel, and others. (2017). Pharmacologic and Nonpharmacologic Treatment for Acute Cough Associated With the Common Cold: CHEST Expert Panel Report. CHEST. 152; 5: 1021—1037. Published online: August 22.

20. Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, Dilworth DA, Berlin CM Jr. (2004). Effect of dextrometh orphan, diphenhy dramine, and place boonnocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 114: 85—90.

21. Płusa T et al. (2017). Butamiratecitrate in control of cough in respiratory tract inflammation. Pol Merkur Lekarski. 43(254): 69—74.

22. Schroeder K, Fahey T. (2005). Over the countermedications for acute cough in children and adults in ambulatory settings. In: The Cochrane Library, Issue 2. Chichester: John Wiley&Sons.

23. Shields MD, Bush A, Everard ML et al. (2008, Apr). BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax. 63; 3: 1—15. Epub Sep 28.

24. Shoaib Faruqi, Caroline Wright, Rachel Thompson, Alyn H Morice. (2014, Dec.). A randomized placebo controlled trial to evaluate the effects of butamirate and dextromethorphan on capsaicin induced cough in healthy volunteers. Br J Clin Pharmacol. 78(6): 1272—1280. Published online 2014 Nov 20. doi 10.1111/bcp.12458PMCID: PMC4256617.

25. Smith SM, Schroeder K, Fahey T. (2014, Nov). Over-the-counter (OTC) medications for acute cough in children and adultsin community settings. Cochrane Data base Syst Rev. 24(11): CD001831. doi 10.1002/14651858.CD001831.pub5.

26. Smith SM, Schroeder K, Fahey Т. (2012, Aug 15). Over-the-counter (OTC) medications for acute cough in children and a dults in ambulatory settings. Cochrane Database Syst Rev. 8: CD001831. doi 10.1002/14651858.CD001831.pub4.

27. US Food and Drug Administration. Codeine cough-and-cold medicines in children: drug safety communication — FDA evaluating potential risk of serious side effects (2015, July 7). Accessed May 12, 2016.

28. Vernacchio LL, Kelly JP, Kaufman DW, Mitchell AA. (2008). Cough and cold medication use by US children, 1999—2006: results from the

slonesurvey. Pediatrics. 122(2): 323—9. doi 10.1542/peds.2008-0498.

29. Worrall G. (2011Б Mar)Ю Acute cough in children. Can Fam Physician. 57(3): 315—318.